There has been a large amount of interest shown in the development of therapeutic molecules from biotechnology. Recombinant DNA and monoclonal antibody technologies have led to the development of therapeutic proteins. Several of these molecules have recently been licensed as drugs and many more are under development. However, discussion of the pharmacology and toxicology of these molecules has been limited to drug companies and hence this book brings the subject of therapeutic proteins to the interested reader.
Read More
There has been a large amount of interest shown in the development of therapeutic molecules from biotechnology. Recombinant DNA and monoclonal antibody technologies have led to the development of therapeutic proteins. Several of these molecules have recently been licensed as drugs and many more are under development. However, discussion of the pharmacology and toxicology of these molecules has been limited to drug companies and hence this book brings the subject of therapeutic proteins to the interested reader.
Read Less
